logo Standing Up To Powerful Interests

Safe and Affordable Prescription Drugs

 

What's New

CALPIRG-backed federal drug safety legislation was enacted late in 2007, helping to prevent another Vioxx-type tragedy by requires drug makers to release the results of their safety studies on-line and beefing up the fines FDA can levy on drug makers who break the rules.

This year, we're working in California to make sure our state's residents get the safe, affordable drugs they deserve. 

First, we're supporting a bill that will hold drug companies accountable if they don't tell the whole truth about the dangers of their products.  Merck has used a century-old legal doctrine to hide from liability for failing to come clean about the risks of Vioxx -- we're working to get rid of this technical defense and make drug companies play by the same rules as everybody else.

Safe drugs also need to be affordable in order to benefit Californians, which is why we helped pass the Discount Prescription Drug program in 2006.  This program will help the uninsured and underinsured get a fair price for their prescription drugs, by allowing the state to negotiate on their behalf.  But the budget deficit threatens the project's funding.  We're fighting to make sure the discount program gets the resources it needs to save working Californians up to 40% on the cost of the medicine they need.



Overview

Pharmaceutical companies make important life-saving medicines. But that shouldn't give them license to drive up drug prices, ignore the risks of harmful side effects, or block needed reforms in California and in Congress. Consider:

• Pharmaceutical companies use direct-to-consumer ads to sell their latest, most expensive drugs. The industry claims that these ads help to educate consumers. But that doesn’t compute with the fact that a CALPIRG analysis of FDA records for the years 2001-2005 found that the ads for 150 different drugs were false or misleading.

• Merck, the manufacturer of Vioxx, continued to market its painkiller to doctors and patients without warning them of the substantial evidence that the drug increased the risk of heart problems. FDA researchers estimate that, in less than 5 years, Vioxx may have caused as many as 139,000 heart attacks and strokes.

• Insurance companies negotiate discount prices on the drugs they buy for their enrollees, but the uninsured and underinsured pay full price, because they don't have the bargaining power to get a fair deal.

CALPIRG is working to get the state to negotiate for a better price on drugs, hold drug companies accountable when they don't tell the whole truth about their products, and get misleading marketing out of the decision of which drug to take.




DECEPTIVE AD PULLED—The drug Paxil, intended to treat social anxiety disorder, made headlines for side effects like teen suicide and severe withdrawal symptoms. Drugmaker GlaxoSmithKline ran television ads that promised relief from shyness and self-consciousness, expanding the scope of the drug. The FDA later pulled the ad. (Source: FDA’s letter to GlaxoSmithKline)

News

House Passes Prescription Drug Safety Reforms

The House today passed significant reforms to the Food and Drug Administration’s drug safety review system. Part of a comprehensive FDA bill, the bill was a compromise between Senate and House legislation that passed overwhelmingly earlier this year. The bill, which includes strong consumer protections, will be voted on in the Senate tomorrow. 

Senate Passes Drug Safety Legislation: Bill Will Protect Patients From Unsafe Medicines 

In a victory for consumers, the Senate today passed the “Food and Drug Administration Revitalization Act” sponsored by Senator Ted Kennedy (D-Mass.) by a vote of 93 to 1.

Newsroom



Reports

Paying the Price: The High Cost of Prescription Drugs for Uninsured Americans

7/11/2006 Millions of uninsured and underinsured Americans struggle to afford the medicines they need, even forgoing medically necessary drugs when prices are out of reach. Download Report

Turning Medicine Into Snake Oil: How Pharmaceutical Marketers Put Patients At Risk

5/3/2006 Prescription drug marketers made deceptive claims to doctors and consumers about 150 different drugs including Vioxx and OxyContin, according to a new report released today by U.S. Public Interest Research Group and the NJPIRG Law and Policy Center. Download Report

 

More Reports



Resources

CALPIRG letter opposing legislation that would expand drug company marketing by allowing pharmacies to sell patient data

CALPIRG letter supporting legislation to hold accountable drug companies who don't come clean about the risks of their products

CALPIRG letter urging lawmakers to fund the Discount Prescription Drug Program



 

SEARCH THIS SITE